CBN’s stimulus package: Nigerians to access up to N25m as NIRSAL reopens portal

News Media Nigeria

– The application for the CBN’s stimulus package to mitigate the impact of COVID-19 has been reopened

Advertisement
Ad imageAd image

– According to NIRSAL, the microfinance bank in charge of the disbursement, individuals can access up to N25 million under the credit facility

Advertisement
nlngnlng

– There are three main categories which include households, microenterprises and SMEs

The Central Bank of Nigeria (CBN), through NIRSAL Microfinance Bank, has reopened its portal for Micro Small and Medium Enterprises (SMEs) and households affected by the COVID-19 pandemic.

Advertisement
Ad imageAd image

President Muhammadu Buhari’s personal assistant on new media, Bashir Ahmad, disclosed this via his Twitter handle on Wednesday, March 10.

Legit.ng gathers that the development has also been confirmed by NIRSAL which added that Nigerians will access up to N25 million in the stimulus package initiative.

The CBN has earmarked N50 billion Targeted Credit Facility (TCF) for the social interventionist programme.

Ahmad tweeted:

Advertisement
Ad imageAd image

 

“The CBN, through @NirsalMFB introduces a stimulus package to support households and MSMEs affected by the COVID-19 pandemic. An individual can access up to N25million.”

According to the information available on NIRSAL’s website, there are three categories of eligible beneficiaries, namely; households, microenterprises and SMEs.

Households

In this category, households eligible for the loan are those with verifiable evidence to show that their livelihood has been adversely impacted by the COVID-19 pandemic.

Microenterprises

Those to benefit from the credit facility in this category are the existing enterprises with verifiable evidence to show that their business activities have been negatively affected as a result of the COVID-19 pandemic.

SMEs

This category is open for enterprises with bankable plans to take advantage of opportunities arising from the COVID-19 pandemic.

 

Share This Article
Leave a Comment